Ingredion Incorporated (INGR) Earnings: Q3 2026 Results and Next Report Date

The quarter ended September 30, 2026 and Ingredion published the results on November 5, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Ingredion reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted diluted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Ingredion sold 51% of its Pakistan business (Rafhan Maize Products) to Nishat Group on June 30, 2026, so Q3 2026 no longer includes it. The release puts the lost volume at $65 million of Q3 net sales.
• On June 8, 2026 Ingredion agreed an all-cash offer for Tate & Lyle PLC, valued at about $3.5 billion. The acquisition was still pending at September 30, 2026.

Source: Ingredion Q3 2026 results, November 5, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Ingredion splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Ingredion's Texture & Healthful Solutions revenue was $610 million in Q3 2026, up 1% from $605 million in Q3 2025, 34% of total revenue.
• Ingredion's Food & Industrial Ingredients - LATAM revenue was $624 million in Q3 2026, up 7% from $585 million in Q3 2025, 35% of total revenue.
• Ingredion's Food & Industrial Ingredients - U.S./CAN revenue was $504 million in Q3 2026, down 1% from $507 million in Q3 2025, 28% of total revenue.
• Ingredion's All Other revenue was $54.0 million in Q3 2026, down 55% from $119 million in Q3 2025, 3% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, Ingredion said:

“The Company now expects its full-year 2026 reported diluted EPS to be in the range of $8.04 to $8.49, and its adjusted diluted EPS to be in the range of $9.25 to $9.70.”

“The Company now expects full-year 2026 net sales to be flat, reflecting volume growth and favorable foreign exchange, offset by lower price mix as well as the impact of the previously mentioned sale of its majority stake in the Pakistan business.”

“Reported operating income is expected to be down low double digits, with adjusted operating income now expected to be down mid-teens for full-year 2026”

“Cash from operations for the full year 2026 is now expected to be in the range of $650 million to $750 million.”

Source: Ingredion Q3 2026 release, Nov 5, 2026.

This is the company's own guidance as of Nov 5, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the INGR forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP net sales and diluted EPS, each as first reported in that quarter's release. Q2 2026 includes the costs of the thermal event at the Argo facility in Bedford Park, Illinois.

Ingredion's next report is expected around February 2, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 5, 2026

Ingredion sells starches, sweeteners and specialty ingredients to food, beverage and industrial manufacturers through three reportable segments. In Q3 2026 Texture & Healthful Solutions had net sales of $610 million, Food & Industrial Ingredients - LATAM $624 million and Food & Industrial Ingredients - U.S./CAN $504 million. All Other, mainly stevia from PureCircle and pea protein, was $54 million. Total net sales were $1,792 million, down 1%. (Ingredion Q3 2026 release, Nov 5, 2026)

The decline came from the sale of the majority stake in the Pakistan business, which removed $65 million of volume. Excluding Pakistan, Ingredion said net sales rose 2%, driven by favorable foreign exchange and higher volumes in F&II - LATAM and T&HS. Foreign exchange added $26 million and volume $21 million, while price mix took away $6 million. (Ingredion Q3 2026 release, Nov 5, 2026)

T&HS grew volume for the tenth consecutive quarter, which Ingredion credits to demand for clean label ingredients. F&II - LATAM sales rose 7%, with stronger volume from brewing and beverage customers in Mexico and Brazil; F&II - U.S./CAN sales fell 1% as volume dropped $15 million, partly offset by $13 million of price mix. (Ingredion Q3 2026 release, Nov 5, 2026)

Food makes up 58% of Ingredion's net sales, beverage 9%, brewing 7% and animal nutrition 7%, according to its 2025 10-K. No customer or group of related customers accounted for 10% or more of net sales in 2025, 2024 or 2023. (Ingredion Form 10-K, 2025, Feb 17, 2026)

Ingredion's reported diluted EPS fell to $2.23 from $2.61, and adjusted diluted EPS to $2.28 from $2.75. The release attributes $0.72 of the decline in adjusted EPS to margin, partly offset by volume ($0.05), foreign exchange ($0.04) and fewer shares outstanding ($0.06). Operating income fell 19% to $201 million; F&II - U.S./CAN segment operating income fell to $52 million from $81 million because of higher manufacturing expenses at the Argo facility and lower volumes. (Ingredion Q3 2026 release, Nov 5, 2026)

Adjusted EPS excludes acquisition and integration costs ($0.09 a share), impairment charges ($0.08) and tax items and other matters ($0.06), and adds back a net restructuring benefit of $0.18. The reported effective tax rate was 26.8%, against 28.6% a year earlier; the adjusted rate was 26.4% in both periods. (Ingredion Q3 2026 release, Nov 5, 2026)

Diluted weighted average shares were 63.7 million, against 65.4 million a year earlier. Ingredion repurchased $85 million of common stock through September 30 against a $100 million full-year target, and raised its quarterly dividend to $0.83 per share. (Ingredion Q3 2026 release, Nov 5, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Ingredion gives a full-year outlook in its release and lowered it with Q3 results. It now expects 2026 reported diluted EPS of $8.04 to $8.49 and adjusted diluted EPS of $9.25 to $9.70, flat net sales, and adjusted operating income down mid-teens. CEO Jim Zallie said the cut mainly reflects the slower earnings recovery in F&II - U.S./CAN, along with higher input costs and softer demand. (Ingredion Q3 2026 release, Nov 5, 2026)

By segment, Ingredion expects T&HS operating income flat to up low single digits, F&II - LATAM down mid-to-high single digits and F&II - U.S./CAN down 35-40%, driven by operating costs at Argo. The guidance excludes acquisition-related integration and restructuring costs. (Ingredion Q3 2026 release, Nov 5, 2026)

A consensus figure is the average of the models published by the analysts who cover Ingredion, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Ingredion's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning INGR is on is INGR a buy or a sell?, what analysts expect next is on the INGR forecast, and what the company does is on the Ingredion Incorporated (INGR) stock page.

Every number on this page can be traced to a document Ingredion published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.